Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure (Q34504604)

2 August 2017

Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

systolic heart failure

1 reference

W H Wilson Tang

1

1 reference

2 August 2017

Yuping Wu

2

1 reference

2 August 2017

Shirley Mann

3

1 reference

2 August 2017

Michael Pepoy

4

1 reference

2 August 2017

Kevin Shrestha

5

1 reference

2 August 2017

Allen G Borowski

6

1 reference

2 August 2017

Stanley L Hazen

7

1 reference

2 August 2017

9 November 2010

1 reference

Circulation: Heart Failure

2 August 2017

1 reference

2 August 2017

4

1 reference

2 August 2017

1

1 reference

2 August 2017

59-64

1 reference

Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Paraoxonases role in the prevention of cardiovascular diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

The paraoxonases: role in human diseases and methodological difficulties in measurement.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

The microcirculation in health and critical disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Increased formation of F(2)-isoprostanes in patients with severe heart failure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Low HDL levels as the most common metabolic syndrome risk factor in heart failure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

High-density lipoprotein cholesterol levels and prognosis in advanced heart failure

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Association of HDL cholesterol and triglycerides with mortality in patients with heart failure

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Differential effects of lipids on the risk of heart failure and coronary heart disease: the Physicians' Health Study.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Decreased serum lipoprotein levels as a guide for clinical severity in patients with idiopathic dilated cardiomyopathy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Urinary biopyrrins levels are elevated in relation to severity of heart failure.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023838

Usefulness of anti-oxidized LDL antibody determination for assessment of clinical control in patients with heart failure

27 October 2018

1 reference

12 December 2020

Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers

1 reference

12 December 2020

The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure

1 reference

12 December 2020

Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart

1 reference

12 December 2020

The human serum paraoxonase/arylesterase polymorphism

1 reference

12 December 2020

Increased malondialdehyde in peripheral blood of patients with congestive heart failure

1 reference

12 December 2020

Association between PON 1 polymorphisms, PON activity and diabetes complications

1 reference

12 December 2020

10.1161/CIRCHEARTFAILURE.110.958348

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference